4//SEC Filing
Murugan Amar 4
Accession 0001140361-23-040563
CIK 0001604464other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:25 PM ET
Size
6.6 KB
Accession
0001140361-23-040563
Insider Transaction Report
Form 4
Murugan Amar
SVP, GC & Secretary
Transactions
- Sale
Common Stock
2023-08-16$1.65/sh−3,622$5,987→ 265,391 total - Sale
Common Stock
2023-08-16$1.65/sh−5,050$8,343→ 269,013 total
Footnotes (3)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
- [F3]Includes 3,118 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2023.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001809916
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:25 PM ET
- Size
- 6.6 KB